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Lewy body disease
• In the case of Lewy body disease, αsynuclein builds up within neurons,
leading to cell death
• This protein especially aggregates
within the basal ganglia, which leads to
movement impairment
• These movement impairments are the
reason Lewy body disease is closely
linked with Parkinson’s disease

Parkinson’s Disease
• The definition of Parkinson’s disease is generally
loose
• Parkinson’s Disease (PD) is diagnosed based on a
series of symptoms rather than a single cause
• Symptoms include
•
•
•
•

Bradykinesia
Rigidity
Postural instability
Tremors

• Usually, the result of lifestyle rather than genetic
factors

Parkinson’s Disorders
Lewy Body Disease
• Build of α-synuclein protein in neurons
• Somatic deficits

Multiple System Atrophy
• Build up of α-synuclein in glial cells
• Autonomic deficits

Progressive Supranuclear Palsy
• Build up of tau protein
• Characteristic eye movements

Corticobasal Degeneration
• Build up of tau protein
• Limb problems

Basal Ganglia
• Facilitates motor movement
• Composed of five parts: (1) caudate, (2) putamen, (3) globus pallidus,
(4) substantia nigra, and the (5) subthalamic nucleus

Denervation in substantia nigra & striatum
• Dopaminergic cells of the substantia nigra die because of an excess of
calcium ions in the basal ganglia
• This calcium-induced cell death is accompanied by buildup of αsynuclein proteins which kills cells as well
• Thus, the substantia nigra is severely disfigured in Lewy body disease
patients
• The input device (striatum) is also dying, leading to poorer reception
and communication → reduced motor movement

Postmortem characterization of PD patients
• The researcher investigated 132 patients diagnosed with Parkinson’s
disorder and found that Lewy Body disease (build up of α-synuclein)
was the cause in most of these patients

Misdiagnosis in neurodegenerative diseases
• “The diagnostic accuracy of pathologically confirmed MSA in the
Mayo Clinic brain bank is less than that for PSP (about 70%).”
• “Cases with autopsy confirmed MSA are most often misdiagnosed
clinically as either PSP (47%) or atypical PD (34%).”
• There seems to be a theme of misdiagnosis in neurodegenerative
disorders.
• What are some potential issues that arise when misdiagnosing these
disorders?
• What could we do to prevent misdiagnosis?

Postmortem studies
• The author believes that postmortem
stories are the most accurate as
scientists can confirm the development
of protein aggregates in specific
locations
• However, the same level of accuracy is
not achieved in antemortem diagnosis
and treatment
• Detection tools should be developed to
better diagnose patients while they are
living

Genes affecting PD development
• PD onset as the result of inheritance is
uncommon (no clear genetic link)
• However, several proteins can play a role
•
•
•
•
•
•

Dysfunctional α-synuclein protein
LRRK2
DCTN1 → Perry Syndrome
POLG1
PINK1 (established)
PRKN (established)

Braak stages in PD development
• Stages 1-2: protein aggregates are largely
within the medulla oblongata and the
olfactory bulb (affecting autonomic
functions and smell)
• Stages 3-4: Pathological changes in
substantia nigra
• By now, the symptoms are evident

• Stages 5-6: Inclusions in the cerebral
cortex
• Day to day life is severely affected

Conclusion
• This survey of autopsies demonstrates the importance of analyzing
postmortem brains to study neurodegenerative disease development
• Misdiagnosis of neurodegenerative disorders can be traced to the lack
of accurate detection tools
• Analyzing autopsies can reveal the physiological differences in
patients with PD (synucleinopathy vs. tauopathy)

Discussion Questions
• Many of the problems involving the differences in neurodegenerative
diseases lie in the general definitions. Should we try to diffuse the
idea of Parkinson’s disease and promote more specific pictures like
Lewy body buildup or tau protein buildup (as in Alzheimer’s disease)?
• What is the causing the difficulty in diagnosing these diseases as the
patients are alive? Should doctors use more invasive methods (e.g.
biopsy) to diagnose disease?
• Many of the current treatments for neurodegenerative diseases are
not disease-modifying. They attack the symptoms instead. How can
we produce disease-modifying treatments?

Discussion Questions
• There is a wide variety
of diseases causing PD.
How would this hinder
or help the awareness
and treatment of this
disease?
• Should we switch to osteopathic forms of medicine rather than
allopathic forms of medicine for patients that do not have geneticallylinked disorders? That is, should doctors put a greater emphasis on
lifestyle changes rather than the medicines they prescribe for patients?
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